Daara Patel on why genericisation of medicines as an initiative will not work in India

By EP News Bureau on June 2, 2017

Related Posts

Less Stress. More Peace of Mind.

UK’s NHS post Brexit: Get updated!

India’s AMR Policy – Get Updated!

Keynote Address by Dr Ramesh Jhawar, President, Ajanta Pharma ~ Molecule to market | FDD 2019

Dr Ashok Omray, President, Ideal Cures and Dr Akshay Kohli, Senior Manager-Technical, Ideal Cures | FDD 2019

Dr Ranjit Barshikar, QbD/CGMP Consulting, United Nations Consultant, MPP Geneva | FDD 2019

Complex Generics – An Insight: Dr Girish Jain, Head – Global R&D, Slayback Pharma | FDD 2019